Who is sponsoring NCT05945420?

NCT05945420 is sponsored by Mansoura University.

What drugs are being tested in NCT05945420?

Interventions in NCT05945420: Desmopressin Acetate, Placebo.

What condition does NCT05945420 study?

NCT05945420 studies Nocturnal Polyurea in Patients With BPH.

Is NCT05945420 still recruiting?

NCT05945420 is currently status unknown. Last updated 14 July 2023.

Last reviewed 2023-07-14 · How we verify

NCT05945420

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adding Desmopressin to Tamsulosin for Treatment of BPH

Status unknown Phase 4 Last updated 14 July 2023

What this trial tests

Phase 4 trial testing Desmopressin Acetate in Nocturnal Polyurea in Patients With BPH in 160 participants. Status unknown.

Timeline

20 July 2023

Primary endpoint
10 January 2024

10 February 2024

Quick facts

Lead sponsor	Mansoura University
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	160
Start date	20 July 2023
Primary completion	10 January 2024
Estimated completion	10 February 2024
Sites	1 location across Egypt

Drugs / interventions tested

Desmopressin Acetate — full drug profile →
Placebo

Conditions studied

Nocturnal Polyurea in Patients With BPH — all drugs for Nocturnal Polyurea in Patients With BPH →

Sponsor

Mansoura University

Who can join

Adults 50 to 80, male only, with Nocturnal Polyurea in Patients With BPH. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study investigators will add desmopressin for treatment of patients with benign prostatic hyperplasia and nocturnal polyurea

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Desmopressin Acetate

Trials testing the same drug.

NCT04545931 — Posterior Tibial Nerve Stimulation Vs Desmopressin In Children With Primary Monosymptomatic Nocturnal Enuresis · Phase 4 · unknown

Other Mansoura University trials

Trials by the same sponsor.

NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
NCT07509567 — Conventional Palatal Crib Versus Bonded Spurs for Anterior Open Bite Treatment · NA · not yet recruiting
NCT07393178 — Efficacy & Safety of High Power vs. Low Power Holmium Laser in Mini-PCNL for Large Renal Stones · NA · not yet recruiting
NCT07436182 — Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. · Phase 4 · not yet recruiting
NCT07534943 — Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Period · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05945420 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mansoura University
Last refreshed: 14 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05945420.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing